Dialog Box

Steering Committee

NOA Co-Chairs


Professor John Zalcberg OAM

Head, Cancer Research Program in the School of Public Health and Preventive Medicine within the Faculty of Medicine, Nursing and Health Sciences at Monash University.

Richard Vines

Chair & Chief Executive, Rare Cancers Australia;
Deputy Chair, Australian Genomics Cancer Medicine Program;
Co-chair, Consumer Advisory Board, Australian Genomic Health Alliance (AGHA);
Director, Patient Voice Initiative.


Pillar Heads

NOA believes that change comes through collaboration and it works across a number of groups that support and underpin it’s goals - NOA calls those groups ‘pillars’ and they’re categorised by the shared experience of the members of the group. Pillar Heads report to the Steering Committee.

Patient Pillar

TBA

Patient Group Pillar

Peter Orchard
Ceo, CanTeen

Clinician Pillar

Prof. Clare Scott
Walter + Eliza Hall Institute of Medical Research

Prof. David Thomas
NHMRC Principal Research Fellow, Director, Kinghorn Cancer Centre and Head of the Centre Division, Garvan Institute of Medical Research

Industry Pillar

Liz Chatwin
Country President, AstraZeneca

 


Steering Committee

  • Liz Chatwin
    Country Manager, AstraZeneca
  • Bruce Goodwin
    Managing Director, Janssen
  • Jane Kerr
    General Manager, Thoracic Cancers & Rare Lung Disease, Lung Foundation
  • Barrie Littlefield
    Head of Engagement, Cure Brain Cancer Foundation
  • Jonathan Pincus
    Patient Advocate
  • Peter Orchard
    CEO, CanTeen
  • Nicola Richards
    Executive Director, Market Access & Public Affairs, MSD
  • Professor Clare Scott
    Walter + Eliza Hall Institute of Medical Research
  • Professor David Thomas
    NHMRC Principle Research Fellow, Director, Kinghorn Cancer Centre and Head of the Cancer Division, Garvan Institute NSW Garvan Institute of Medical Research
Donate